Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gelareh A Abulwerdi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Chembiochem : a European Journal of Chemical Biology|August 3, 2010
Quantifying prefibrillar amyloids in vitro by using a "thioflavin-like" spectroscopic methodAshley A Reinke, Gelareh A Abulwerdi, Jason E Gestwicki
Clinical Pharmacology and Therapeutics|July 25, 2025
Pediatric Hepatic Impairment Dosing in FDA Approvals Between 2002 and 2024Deandra A Cassel, Gilbert J Burckart, Martina D Sahre, et al.
Clinical and Translational Science|August 8, 2023
Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020Gelareh A Abulwerdi, Anuradha Ramamoorthy, Edward Bashaw, et al.
NPJ Aging and Mechanisms of Disease|July 20, 2017
Cytochrome <i>b</i><sub></sub> reductase and the control of lipid metabolism and healthspanAlejandro Martin-Montalvo, Yaning Sun, Alberto Diaz-Ruiz, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Chembiochem : a European Journal of Chemical Biology|August 3, 2010
Quantifying prefibrillar amyloids in vitro by using a "thioflavin-like" spectroscopic methodAshley A Reinke, Gelareh A Abulwerdi, Jason E Gestwicki
Clinical Pharmacology and Therapeutics|July 25, 2025
Pediatric Hepatic Impairment Dosing in FDA Approvals Between 2002 and 2024Deandra A Cassel, Gilbert J Burckart, Martina D Sahre, et al.
Clinical and Translational Science|August 8, 2023
Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020Gelareh A Abulwerdi, Anuradha Ramamoorthy, Edward Bashaw, et al.
NPJ Aging and Mechanisms of Disease|July 20, 2017
Cytochrome <i>b</i><sub></sub> reductase and the control of lipid metabolism and healthspanAlejandro Martin-Montalvo, Yaning Sun, Alberto Diaz-Ruiz, et al.
Pageof 1